Correlation Between Diamyd Medical and Corteva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and Corteva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and Corteva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and Corteva, you can compare the effects of market volatilities on Diamyd Medical and Corteva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of Corteva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and Corteva.

Diversification Opportunities for Diamyd Medical and Corteva

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Diamyd and Corteva is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and Corteva in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corteva and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with Corteva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corteva has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and Corteva go up and down completely randomly.

Pair Corralation between Diamyd Medical and Corteva

Assuming the 90 days horizon Diamyd Medical is expected to generate 1.01 times less return on investment than Corteva. In addition to that, Diamyd Medical is 2.38 times more volatile than Corteva. It trades about 0.05 of its total potential returns per unit of risk. Corteva is currently generating about 0.12 per unit of volatility. If you would invest  5,002  in Corteva on September 12, 2024 and sell it today you would earn a total of  645.00  from holding Corteva or generate 12.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  Corteva

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.
Corteva 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Corteva are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Corteva unveiled solid returns over the last few months and may actually be approaching a breakup point.

Diamyd Medical and Corteva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and Corteva

The main advantage of trading using opposite Diamyd Medical and Corteva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, Corteva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corteva will offset losses from the drop in Corteva's long position.
The idea behind Diamyd Medical AB and Corteva pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation